Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae
Asthma is a common inflammatory disease of the airways. Current therapies alleviate symptoms but do not treat the disease. We aim to develop effective immunomodulatory therapies (IMTs) for asthma that target the underlying causes of disease based on Streptococcus pneumoniae (Spn). The effect of Spn IMT on the development of asthma [allergic airways disease (AAD)] was determined in mice. Killed Spn was administered before, during or after ovalbumin sensitization, and the subsequent development...[Show more]
|Collections||ANU Research Publications|
|01_Preston_Inhibition_of_allergic_airways_2007.pdf||571.66 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.